Efficacy and Safety of Cagrilintide Alone and in Combination with Semaglutide (Cagrisema) as Anti-Obesity Medications: A Systematic Review and Meta-Analysis
No meta-analysis has analysed role of cagrilintide as weight-loss medication in obese individuals. Electronic databases were searched for RCTs involving obese individuals receiving cagrilintide or cagrilintide-2.4 mg with semaglutide-2.4 mg combination (Cagrisema) compared to placebo/active comparat...
Сохранить в:
| Главные авторы: | , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Wolters Kluwer Medknow Publications
2024-11-01
|
| Серии: | Indian Journal of Endocrinology and Metabolism |
| Предметы: | |
| Online-ссылка: | https://journals.lww.com/10.4103/ijem.ijem_45_24 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|